Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 109 clinical trials
None
A 52-week Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)

The purpose of the study is to evaluate the efficacy and safety of two doses of CHF6001 (Tanimilast), as add-on to maintenance triple therapy in the target patient population.

  • 0 views
  • 12 Aug, 2021
  • 1 location
None
A 52-week Placebo- and Active- Controlled (Roflumilast Daliresp 500 g) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.

  • 0 views
  • 11 Aug, 2021
  • 1 location
None
HHHFA in COPD Patients With Chronic Bronchitis

Heated, humidified high-flow air (HHHFA) devices improve airway clearance. HHHFA use for an average of 1.6 hours a day in COPD patients with chronic bronchitis improves health-related quality of

  • 0 views
  • 08 Apr, 2021
  • 1 location
None
Suctioning of NOse Therapy in Bronchiolitis

Research Questions: Primary In otherwise healthy infants 4 weeks to 12 months of age discharged home from the ED with acute bronchiolitis,1 is there a difference in the probability of "treatment failure" by 72 hours post discharge from the index ED visit in those receiving nasal suctioning via Zo-Li device …

acute bronchiolitis
respiratory distress
asthma
  • 0 views
  • 24 Jan, 2021
  • 3 locations
None
Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

Plastic bronchitis (PB) is a rare, most often pediatric disease characterized by the formation of obstructive airway casts primarily composed of fibrin. There is presently no FDA-approved

Accepts healthy volunteers
  • 44 views
  • 30 Oct, 2021
  • 6 locations
None
High Flow Nasal Cannula Therapy in Bronchiolitis : Early vs Rescue

The enrolled RSV-bronchiolitis patients will be randomized into two arms , the early HHHFNC group and the standard therapy group with rescue HHHFNC to study the efficacy of this treatment.

  • 3 views
  • 01 Sep, 2021
  • 1 location
None
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD

Evaluation of immunogenicity and safety of the subjects aged 60 years and above with chronic bronchitis and chronic obstructive pulmonary disease recruited to receive the schedule of two doses

pulmonary disease
COPD
  • 0 views
  • 27 Oct, 2021
  • 1 location
None
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged 60 Years With Chronic Bronchitis and COPD

Evaluation of immunogenicity and safety of the subjects aged 60 years and above with chronic bronchitis and chronic obstructive pulmonary disease recruited to receive the schedule of three doses

pulmonary disease
COPD
  • 0 views
  • 28 Oct, 2021
  • 1 location
None
Assessment of NeuroBOX and NeuroPAP in Infants.

Non-invasive ventilation (NIV, delivered via a mask or cannulas) permits to reduce the need for tracheal intubation in infants who needs a ventilatory support. NIV can be delivered with nasal CPAP (continuous positive airway pressure) or NIPPV (nasal intermittent positive pressure ventilation). The synchronization of the respiratory support according to …

  • 0 views
  • 25 Mar, 2021
  • 1 location
None
Comparing the Efficacy of Two Valved Holding Chambers in Acute Wheezing

The incidence of physician confirmed asthma is approximately 4-7% in children. An additional 5% of children suffer from infection-related bronchiolitis and obstructive bronchitis. Of all patient

  • 4 views
  • 22 Jan, 2021
  • 4 locations